PMP22 and Charcot-Marie-Tooth disease: Thus, the overexpression of wild-type PMP22 or of mutant PMP22 can lead to elevated intracellular Ca2+ levels, and modulation of intracellular calcium levels might improve the homeostasis of Schwann cells, thereby ameliorating the demyelinating phenotype of CMT.